PharmaShots | Incisive News in 3 Shots

Subscribe Now

Hemophilia A and B

Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B

Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B

August 13, 2020

Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

March 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us